Get the Stockscreener App
3.61
0.82%
-0.03
After Hours:
3.64
0.03
+0.83%
Sonoma Pharmaceuticals Inc stock is traded at $3.61, with a volume of 32,389.
It is down -0.82% in the last 24 hours and up +11.42% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$3.64
Open:
$3.6
24h Volume:
32,389
Relative Volume:
0.79
Market Cap:
$6.14M
Revenue:
$14.91M
Net Income/Loss:
$-3.56M
P/E Ratio:
-1.4679
EPS:
-2.4593
Net Cash Flow:
$-1.37M
1W Performance:
+1.12%
1M Performance:
+11.42%
6M Performance:
+25.78%
1Y Performance:
+31.27%
1-Day Range:
$3.46
$3.68
1-Week Range:
$3.46
$3.7979
52-Week Range:
$1.75
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
3.61 | 6.19M | 14.91M | -3.56M | -1.37M | -2.4593 |
|
ZTS
Zoetis Inc
|
126.23 | 55.30B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.65 | 49.22B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.13 | 44.97B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.89 | 36.41B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
507.16 | 22.16B | 3.08B | 1.24B | 1.07B | 25.61 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
Fundamentals Check: Will Sonoma Pharmaceuticals Inc. stock benefit from M&A activity2025 Bull vs Bear & Precise Buy Zone Identification - moha.gov.vn
Intraday Charts Show Spike in Vineet Laboratories Limited ActivityLow Beta Stocks & Low Cost Market Tips - Bollywood Helpline
Will Sonoma Pharmaceuticals Inc. stock beat EPS estimates2025 Historical Comparison & Weekly Stock Performance Updates - DonanımHaber
Why Sonoma Pharmaceuticals Inc. stock could see breakout soonJuly 2025 Recap & Consistent Profit Trade Alerts - DonanımHaber
Is Sonoma Pharmaceuticals Inc. stock attractive for growth ETFs2025 Market WrapUp & Weekly High Return Forecasts - DonanımHaber
Published on: 2025-12-18 21:37:00 - Улправда
Dividend Income and re investment StrategyInterest Rate Changes & Discover Top Gainers in Every Sector - Bollywood Helpline
Demand for Scar Treatment in UK | Global Market Analysis Report2035 - Fact.MR
What analysts say about Sonoma Pharmaceuticals Inc stockMoving Average Strategies & Free Real-Time Trading Alerts Every Day - earlytimes.in
What analysts say about Sonoma Pharmaceuticals Inc O8Z stockConsumer Goods Stocks & Low Risk Trading Plans - earlytimes.in
Sonoma Pharmaceuticals (SNOA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why Sonoma Pharmaceuticals Inc. (O8Z) stock appeals to dividend investorsWeekly Stock Recap & Real-Time Volume Surge Alerts - Newser
How Sonoma Pharmaceuticals Inc. (O8Z) stock compares with tech leadersJuly 2025 PostEarnings & Real-Time Volume Analysis - Newser
Sonoma Pharmaceuticals, Inc. (SNOA) 10.6% in After-hours: Strong Surge Amid Routine Trading - Stocks Telegraph
What drives Sonoma Pharmaceuticals Inc stock priceAnalyst Downgrades & Free High Return Strategy Alerts - earlytimes.in
Sonoma Pharmaceuticals Inc. (SNOA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Woodward reports record sales, earnings for 2025 - BizWest
Sonoma Pharmaceuticals, Inc.Common Stock (NQ: SNOA - Markets Financial Content
Sonoma Pharmaceuticals, Inc. (SNOA) stock price, news, quote and history - Yahoo Finance UK
Is Sonoma Pharmaceuticals Inc. (O8Z) stock prepared for digital transitionQuarterly Earnings Report & Technical Confirmation Trade Alerts - newser.com
Why Sonoma Pharmaceuticals Inc. (O8Z) stock appears on watchlistsQuarterly Market Summary & Verified Momentum Stock Alerts - newser.com
Is Sonoma Pharmaceuticals Inc. (O8Z) stock attractive post correctionWall Street Watch & Daily Oversold Bounce Ideas - newser.com
How Sonoma Pharmaceuticals Inc. (O8Z) stock stacks up against competitorsInsider Buying & Real-Time Volume Analysis Alerts - newser.com
How to interpret RSI for Sonoma Pharmaceuticals Inc. stockJuly 2025 Macro Moves & Weekly Consistent Profit Watchlists - newser.com
Published on: 2025-11-19 13:22:41 - newser.com
Will Sonoma Pharmaceuticals Inc. (O8Z) stock rise with strong economyQuarterly Portfolio Review & Free High Return Stock Watch Alerts - newser.com
What downside risks could hit Sonoma Pharmaceuticals Inc. (O8Z) stockJuly 2025 Analyst Calls & Long-Term Growth Stock Strategies - newser.com
Sonoma Pharmaceuticals Inc. stock volume spike explainedJuly 2025 Movers & Accurate Intraday Trading Signals - newser.com
What does recent volatility data suggest for Sonoma Pharmaceuticals Inc.Dividend Hike & Growth Oriented Trading Recommendations - newser.com
Is Sonoma Pharmaceuticals Inc. stock in correction or buying zone2025 Historical Comparison & AI Enhanced Trading Signals - newser.com
Published on: 2025-11-19 00:56:45 - newser.com
New CEOs for AdvanCell, Sonoma - biocentury.com
How analysts revise price targets for Sonoma Pharmaceuticals Inc. (O8Z) stock2025 Technical Overview & Verified Trade Idea Suggestions - newser.com
Sonoma Biotherapeutics Names Stephen Dilly as CEO - Contract Pharma
Predicting Sonoma Pharmaceuticals Inc. trend using moving averages2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Is Sonoma Pharmaceuticals Inc. stock gaining market share2025 Price Momentum & Fast Momentum Entry Tips - newser.com
Published on: 2025-11-16 04:08:08 - newser.com
Intraday pattern recognizer results for Sonoma Pharmaceuticals Inc.Earnings Growth Report & Stepwise Swing Trade Plans - newser.com
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
13.98%
0.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):